MB02: Atrial fibrillation, modern antithrombotic treatment (Study cycle 2025-26)
MB02: Atrial fibrillation, modern antithrombotic treatment (11 hours)
Course leader: Prof. V. Vassilikos
Friday, 14/11/2025
| 16:00-17:00 | Pathophysiology of atrial fibrillation. Is it a special pathological entity of electrophysiological origin or a common manifestation of other heart diseases? | D. Economou |
| 17:00-18:00 | Special characteristics and thromboembolic risk of patients with atrial fibrillation. Epidemiology and socioeconomic significance of the disease. | M. Papamichalis |
| 18:00-18:45
18:45-19:15 |
Antiarrhythmic medication and medication to control heart rate.
Clinical examples. |
B. Vassilikos
B. Vassilikos |
| 19:15-20:00 | Treatment of atrial fibrillation in Greece – The should and the should. | B. Vassilikos |
Saturday, 15/11/2025
| 09:00-10:00 | General principles of pharmacological antithrombotic treatment in atrial fibrillation. | H. Pantsios | |
| 10:00-11:00
11:00-11:30 |
Direct-acting oral anticoagulants and atrial fibrillation.
Clinical examples. |
D. Richter
D. Richter |
|
| 11:30-12:30
12:30-13:00 |
Antithrombotic treatment in special populations: Renal failure, elderly, patients with high bleeding risk.
Clinical examples.
|
G. Andrikopoulos
G. Andrikopoulos |
|
| 13:00-14:00 | Break time | ||
| 14:00-15:00
15:00-15:30 |
Interventional treatments in atrial fibrillation. Their impact on prognosis.
Clinical examples. |
G. Andrikopoulos
G. Andrikopoulos |
|
| 15:30-16:30 | Procedures, indications and use of antithrombotic therapy in atrial fibrillation reversal.
Clinical examples. |
H. Pantsios | |
| 16:30-17:00 | H. Pantsios |
| Date: | November 14-15, 2025 |
| From: | 16:00-20:00 |
| To: | 09:00-17:00 |
